Kinesys is very pleased to announce that our long-term client Soligenix, Inc. has been granted an ILAP ‘Innovation Passport’ by UK MHRA for the company’s novel HyBryte treatment for Cutaneous T-Cell Lymphoma (CTCL). We are delighted to have supported Soligenix,
Kinesys and our collaborators Dr Philippe Motte, Dr Xavier Luria and Manon Dutouya, are delighted to publish in TOPRA Regulatory Rapporteur an insightful article on the current status and potential improvements for Early Access Programmes for new drugs in Europe.
Ishbel is joining Kinesys Consulting as Executive Director Regulatory Affairs. She has been working in the Pharmaceutical industry for over 30 years, starting as an analytical chemist and with 25 years in Regulatory Affairs. She previously worked with Wyeth (now Pfizer), Controlled Therapeutics (now part of Ferring Group) and her own consultancy company, MacDonald Regulatory. Prior
Kinesys Consulting is very pleased to announce the expansion of its practice with the opening of a new office in the heart of Amsterdam, at Gustav Mahlerlaan 1212, 1081 LA Amsterdam, NL.This new location strengthens Kinesys' presence in Europe and provides
We are very excited to announce that Kinesys Consulting, high-quality provider of Regulatory & Product Development support to the Biopharmaceutical industry, will be at the DIA Global Annual Meeting 2019 taking place in San Diego next week. For more than